Records containing: SARS-CoV Infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-12-21A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
-
CLINICAL_TRIALS study record update · 2023-12-13Multicenter, Randomized, Blind, Placebo-controlled Clinical Study of III Phase on Assessment of Preventive Efficiency, Safety and Immunogenicity QazCovid-in®-Vaccine Against COVID-19 in Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2023-12-07Randomized, Blind, Placebo-controlled Phase- I Study and Randomized, Open Phase Phase-II Study of QazCoVac-P - COVID-19 Subunit Vaccine in Healthy Adult Volunteers From 18 Years Old and Elder
-
CLINICAL_TRIALS study record update · 2023-11-28Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients
-
CLINICAL_TRIALS study record update · 2023-11-27SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-10-31Prospective Observational Study Examining Clinical Characteristics, Inflammatory Markers, Treatments and Outcomes of Patients Hospitalized for COVID-19 at the University of Michigan Healthcare System in Ann Arbor
-
CLINICAL_TRIALS study record update · 2023-10-23Evaluation of SARS-CoV-2 Sample Acquisition Efficiency and PPE Usage With and Without the Hexapod Personal Protective Booth
-
CLINICAL_TRIALS study record update · 2023-10-10Evaluation of the Benefit of a Systematic Offer of Nurse-Driven SARS-Cov2 Screening by Rapid Testing in Emergency Departments in the Paris Metropolitan Area
-
CLINICAL_TRIALS study record update · 2023-10-06COMBO Trial: Camostat With Bicalutamide for COVID-19
-
CLINICAL_TRIALS study record update · 2023-08-14Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination
-
CLINICAL_TRIALS study record update · 2023-07-25Lipid Ibuprofen Versus Standard of Care for Acute Hypoxemic Respiratory Failure Due to COVID-19: a Multicentre, Randomised, Controlled Trial
-
CLINICAL_TRIALS study record update · 2023-07-13COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
-
CLINICAL_TRIALS study record update · 2023-07-03Effectiveness of a Novel Respirator With Chitosan Nanoparticles to Reduce the Incidence of SARS-CoV-2 Infection in Healthcare Professionals: Randomized Controlled Trial (VESTA Trial)
-
CLINICAL_TRIALS study record update · 2023-06-15Systemic Allergic Reactions to SARS-CoV-2 Vaccination
-
CLINICAL_TRIALS study record update · 2023-05-26Rapid Research in the CHILD Cohort to Inform Canada's Response to the COVID-19 Pandemic: Investigating the Prevalence & Predictors of SARS-CoV-2 Infection and the Health & Psychosocial Impact of the COVID-19 Pandemic on Canadian Families.
-
CLINICAL_TRIALS study record update · 2023-05-11Potential Mechanisms of Long-term Muscle Weakness and Decreased Exercise Tolerance in Patients Infected by SARS-COV-2
-
CLINICAL_TRIALS study record update · 2023-05-10Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020
-
CLINICAL_TRIALS study record update · 2023-04-18Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS).
-
CLINICAL_TRIALS study record update · 2023-04-07A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 - FIND SARS CoV-2 Covid-19
-
CLINICAL_TRIALS study record update · 2023-04-04International Registry of Healthcare Workers Exposed to COVID-19 Patients (UNITY Global)
-
CLINICAL_TRIALS study record update · 2023-03-09Brazilian COVID-19 Registry for Clinical Presentation of Individuals With COVID-19: a National, Multicentre, Prospective Observational Study (SARS-Brazil)
-
CLINICAL_TRIALS study record update · 2023-03-08Phase III, Random-Open, Clinical Trials on the Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia
-
CLINICAL_TRIALS study record update · 2023-03-03Randomized Controlled Clinical Study (RCT) Phase 3 of the Safety and Efficacy of Hypochlorous Acid in the Prophylaxis of Healthcare Personnel at High Risk of Infection by SARS-CoV2 (COVID19) Versus Placebo
-
CLINICAL_TRIALS study record update · 2023-02-23Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure - Prospective Case Control Study
-
CLINICAL_TRIALS study record update · 2023-02-16Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?